Identification and characterization of KCTD19. To investigate the tissue distribution and developmental expression pattern of Kctd9, RT-PCR analyses were performed. A, Kctd19 gene was transcribed in normal testis but not germ cell-lacking testis (W/Wv). T, testis; B, brain; Li, liver; S, spleen; K, kidney; SK, skeletal muscle; Ov, ovary; G3PDH, glyceraldehyde-3-phosphate dehydrogenase. B, stage-specific expression of Kctd19 was determined from mouse testes on different days after birth (8, 10, 12, 14, 16, 20, 30, and 84 days). C, total lysates from wild-type (WT) mouse testes and germ cell-lacking testes of W/Wv mutant mice were immunoblotted with the anti-KCTD19 antibody. KCTD19 was only found in normal mouse testis. The anti-α-tubulin antibody was used as a control. D, protein samples from testicular cells (TC), testicular sperm (TS), and mature sperm (S) were blotted with anti-KCTD19 and anti-ADAM2 antibodies. The testicular cell-specific expression pattern of KCTD19 was similar to that of Mm.290718/ZFP541. An anti-ADAM2 antibody was used as a control. E, stage-specific expression of KCTD19 during spermatogenesis was examined by immunoblotting using total lysates obtained from prepubertal and adult male mice (aged 8, 16, 21, 28, 35, 42, 49, and 56 days). KCTD19 was present from day 16. The anti-α-tubulin antibody was used as a control.